| Blog entry | Emergent BioSolutions to Release Fourth Quarter and Full Year 2011 Financial Results and Conduct a Conference Call on March 8, 2 | admin |
| Blog entry | Fuad El-Hibri and the TAKREEM Achievement Awards | admin |
| Blog entry | Fuad El-Hibri on Arabian Business Power 500 | admin |
| Blog entry | Fuad El-Hibri Announces Emergent BioSolutionsAward to Supply BioThrax Anthrax Vaccine to U.S. Government | admin |
| Blog entry | FUAD EL-HIBRI TO AWARD 2011 EL-HIBRI PEACE EDUCATION PRIZE TO GENE SHARP | admin |
| Blog entry | Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference in London | admin |
| Blog entry | Fuad El-Hibri Interviewed by Ricardo Karam | admin |
| Blog entry | Emergent Announces Initiation of a Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine | admin |
| Blog entry | Emergent BioSolutions to Present at Wedbush 2011 Life Sciences Conference | admin |
| Blog entry | Fuad El-Hibri and the Heifetz International Music Institute | admin |
| Blog entry | Singapore Health Sciences Authority Approves Emergent BioSolutions Anthrax Vaccine, BioThrax | admin |
| Blog entry | Emergent BioSolutions Reports Financial Results for Full Year 2010 | admin |
| Blog entry | Emergent BioSolutions Chairman and CEO Fuad El-Hibri Appointed to U.S. Chamber of Commerce Board of Directors | admin |
| Blog entry | Emergent BioSolutions' Investigational Anthrax Vaccine, NuThrax, Granted Fast Track Designation | admin |
| Blog entry | Emergent BioSolutions on Track to Complete Delivery of 14.5M Doses of BioThrax to the US Government Ahead of Schedule | admin |
| Blog entry | Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference | admin |
| Blog entry | Emergent BioSolutions Reports Financial Results for First Quarter 2011 | admin |
| Blog entry | Oxford-Emergent Tuberculosis Consortium Vaccinates Last Infant in Phase IIb Clinical Trial | admin |
| Blog entry | Emergent BioSolutions Chairman and CEO Fuad El-Hibri Named Biotech CEO of the Year at the World Vaccine Congress | admin |
| Blog entry | Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference | admin |
| Blog entry | Emergent BioSolutions Observes World TB Day Launches “OETC: Endeavor to End Tuberculosis,” a video to raise public awareness of | admin |
| Blog entry | Delegates from European Parliament Express Support for Rapid Development of New TB Vaccine | admin |
| Blog entry | Emergent BioSolutions to Release Fourth Quarter and Full Year 2010 Financial Results and Conduct a Conference Call on March 10 | admin |
| Blog entry | Emergent BioSolutions Announces Initiation of Phase Ib/II Study of TRU-016 in Combination with Bendamustine for Chronic Lymphocy | admin |
| Blog entry | CEO took roundabout path to Emergent | admin |
